Ayse Feyza Aslan
Overview
Explore the profile of Ayse Feyza Aslan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
63
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aslan A, Demir S, Toprak I, Korkmaz P, Karabacak D, Kahveci N, et al.
Allergy Asthma Proc
. 2025 Feb;
46(2):152-158.
PMID: 40011982
Hypersensitivity reactions (HRs) to iron agents are increasing in parallel with increased use of iron preparations. We aimed to evaluate the clinical features and our previous desensitization protocol in patients...
2.
Celebi Sozener Z, Oguzulgen I, Ozalp Ates F, Baccioglu A, Argun Baris S, Ediger D, et al.
J Asthma
. 2025 Feb;
:1-11.
PMID: 39932533
Objective: The obese-asthma phenotype has gradually increased in the last few years. We aimed to assess the differences between obese and non-obese patients with asthma. Methods: This research is a...
3.
Arslan B, Turk M, Hayme S, Aydin O, Gokmen D, Koycu Buhari G, et al.
Clin Transl Allergy
. 2025 Jan;
15(1):e70018.
PMID: 39865387
Background: Asthma is one of the most common causes of chronic respiratory disease, and countries with low socioeconomic status have both a high prevalence of asthma and asthma-related death. Objective:...
4.
Beyaz S, Erdinc M, Hayme S, Aslan A, Aydin O, Gokmen D, et al.
Allergol Immunopathol (Madr)
. 2025 Jan;
53(1):12-25.
PMID: 39786871
Montelukast, a leukotriene receptor antagonist (LTRA) approved for the treatment of asthma and allergic rhinitis, is widely used, though real-world data on its application in asthma management remain limited. This...
5.
Gemicioglu B, Gokmen D, Can A, Sevinc C, Oguzulgen I, Soyyigit S, et al.
Respir Med
. 2024 Dec;
236:107883.
PMID: 39617354
Current guidelines recommend adding long-acting muscarinic antagonists (LAMAs) in patients with uncontrolled asthma, despite the use of moderate to high doses of inhaled steroid-long-acting beta agonists (ICS/LABA). This study aims...
6.
Demir S, Eyice-Karabacak D, Kocaturk E, Unal D, Toprak I, Korkmaz P, et al.
Clin Transl Allergy
. 2024 Feb;
14(3):e12342.
PMID: 38415974
Background: Determination of control level in recurrent angioedema (RAE) is necessary to guide management. Here, we validated a Turkish version of the angioedema control test (AECT) for 4-week (AECT-4wk) and...
7.
Yegit O, Aslan A, Coskun R, Karadag P, Toprak I, Can A, et al.
World Allergy Organ J
. 2023 Sep;
16(8):100810.
PMID: 37663085
Introduction: In 2020, World Allergy Organization (WAO) updated their diagnostic criteria for anaphylaxis, which differed as a result from the National Institute of Allergy and Infectious Diseases/Food Allergy and Anaphylaxis...
8.
Aslan A, Ortakoylu M, Bagci B, Toprak S
Turk J Med Sci
. 2023 Jul;
53(3):761-770.
PMID: 37476899
Background: Considering its early bactericidal activity, isoniazid (H) is an important first-line agent in tuberculosis (TB) treatment.The aim of this study was to evaluate the treatment regimens and results of...
9.
Celik G, Aydin O, Gokmen D, Koycu Buhari G, Celebi Sozener Z, Gemicioglu B, et al.
J Asthma
. 2023 Apr;
60(11):1973-1986.
PMID: 37096963
Introduction: National data on asthma characteristics and the factors associated with uncontrolled asthma seem to be necessary for every country. For this purpose, we developed the Turkish Adult Asthma Registry...
10.
Aslan S, Guner A, Demir A, Yilmaz E, Aslan A, Celik O, et al.
Perfusion
. 2021 Sep;
38(1):186-192.
PMID: 34590527
Introduction: Chronic obstructive pulmonary disease (COPD) is considered a major risk factor for postoperative complications after transcatheter aortic valve implantation (TAVI). To date, there is no clear consensus on the...